APPOS - Boston

March 4th - March 5th, 2022


Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Boston Time Zone

Friday, March 4, 2022

7:00am Registration Open & Breakfast Available in Exhibit Hall


Horizon CME App Overview

8:10am Welcome, Introductions, & CE Housekeeping


(01) The Evolution of Drug Therapy in Oncology: Recent Advances in Cancer Drug Therapy
» Val Relias, PHarmD - Tufts Medical Center

Exhibit Break
9:45am (02A) Small Cell Lung Cancer: Recent Advances in Therapy
» Catherine B. Meador, MD. PhD

(02B) CAR T-Cell Therapy: Current Status in Oncology
» Caron Jacobson, MD, MMSc Physician Dana Farber Cancer Institute Boston, MD


Break - Refreshments in Exhibit Hall


(03A) Financial Toxicities and Health Equity Access
» Brenda Lormil, NP MGH
» Beverly Moy, MD, MPH - Massachusetts General Hospital  
» Natasha Johnson, LICSW, MSW, MA
- Massachusetts General Hospita


Buffet Lunch & Non-CME/CE Presentation Sponsored by Merck


(04) Integrating Palliative Care in the Daily Oncology Practice
» Barbara Reville, DNP, ANP-C, ACHPN - Harvard Medical School Center for Palliative Care


(05A) Triple-Negative Metastatic Breast Cancer: Expanding Treatment Beyond Chemotherapy
» V. K. Gadi, MD, PhD - Translational Research University of Illinois at Cancer Center​​​​​​

(05B) New Strategies in Chronic Lymphocytic Leukemia
» Hillary Prescott, PharmD, BCOP - Dana-Farber Cancer Institute 


(06) Cancer-Related Thrombosis: The Great Debate on the Best Way to Anticoagulate
» Allison Schepers, PharmD, BCOP - University of Michigan College of Pharmacy
» Danielle Otto, PharmD, BCOP - University of Kentucky Healthcare

Saturday, March 5, 2022

7:00am Check-in & Breakfast Available in Exhibit Hall
8:00am Welcome, Introductions, & CE Housekeeping


(07A) Targeting Advanced Renal Cell Carcinoma
» Laura S. Wood RN, MSN, OCN  - Cleveland Clinic Taussig Cancer Center ​​​​​

(07B) Benign Hematology 101 

9:05am Break - Refreshments in Exhibitor Hall
(08A) Updates and Future Directions in Ovarian Cancer Maintenance Therapy
» Jenny Filipi, NP - Nurse Practitioner Massachusetts General Hospital ​​​

(08B) Managing Patients with Relapsed/Refractory Multiple Myeloma: An Update on Emerging Strategies
» Shahrier Hossain, PharmD  - Clinical Pharmacy Specialist Dana Farber Cancer Institute


Break - Refreshments in Exhibit Hall


(09) Compassion Fatigue & Provider Burnout: How Can Self-Care Strategies Enhance Provider Well-Being?
» Justin Baker, MD - St Jude Children's Research Hospital


Buffet Lunch & Non-CE Symposium Presentation Sponsored by Takeda


Dessert Break in Exhibit Hall


(10) Symptom Management in Oncology: Helping Patients Improve Their Quality of Life
» Kathy Chuang, MD MGH 
» Michael L. Dougan, MD, PhD


(11A) Esophageal and Gastroesophageal Junction Cancers: Startegies in Treatment and Management
» Matthew Strickland, MD - Dana Farber Cancer Institute​​​​​

(11B) Managing Diffuse Large B-cell Lymphoma in 2022: Novel Therapeutic Strategies in the Relapsed/Refractory Setting
» Kaitlen Reyes, FNP, DNP - Dana Farber Cancer Institute 


Closing Comments

Course starts in about 1 month

Base Price $80.00 Advanced Deadline: 2/2/2022